People's United Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

People's United Financial’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-34	Closed	-$3K	–	756
2019 Q1	$3K	Buy	+34	New	+$2.84K	﹤0.01%	709
2018 Q3	–	Sell	-2,130	Closed	-$210K	–	747
2018 Q2	$210K	Hold	2,130	–	–	0.01%	753
2018 Q1	$254K	Hold	2,130	–	–	0.01%	644
2017 Q4	$271K	Buy	+2,130	New	+$268K	0.01%	637
2016 Q1	–	Sell	-2,130	Closed	-$201K	–	862
2015 Q4	$201K	Buy	+2,130	New	+$197K	0.01%	445
2015 Q3	–	Sell	-2,140	Closed	-$256K	–	872
2015 Q2	$256K	Buy	2,140 +10	+0.5%	+$1.2K	0.01%	415
2015 Q1	$222K	Hold	2,130	–	–	0.01%	426
2014 Q4	$207K	Buy	+2,130	New	+$197K	0.01%	437

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

People's United Financial's ALNY Position: Q2 2019 in Review

People's United Financial sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2019, closing a stake of 34 shares — an estimated $3K sold.

People's United Financial first reported a position in ALNY in Q4 2014 and held it in 8 quarters. The position peaked at $271K in Q4 2017. 290 funds tracked by Wall St. Rank hold ALNY as of Q2 2019.

People's United Financial reported no remaining Alnylam Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
People's United Financial sold 34 Alnylam Pharmaceuticals shares in Q2 2019, an estimated $3K.
People's United Financial first reported a position in Alnylam Pharmaceuticals in Q4 2014 and held it in 8 quarters.
People's United Financial's Alnylam Pharmaceuticals position peaked at $271K in Q4 2017.
290 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2019.

Based on People's United Financial's 13F filing for Q2 2019, filed 14 Aug 2019.